Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sickle cell disease acute event frequencies in the United States-A retrospective cohort study using optum electronic health records
Xunming Sun, Yun Gu, Steven Arkin, Stephen E. Schachterle,Xiaofeng Zhou, Thomas Edwards, Shannon Marraffino
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 85-86
Cited0Views0Bibtex
0
0
Social determinants of health and disparities in T2DM severity in the United States
Yaa Ababio,Adina R. Lemeshow,Xiaofeng Zhou, Chunyang Feng, John G. Ryan, Brett South, Leo J. Russo, Mark Cullen
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 127-128
Cited0Views0Bibtex
0
0
Racial disparities in paxlovid use treating for high risk COVID-19 patients-A large population based study using US claim data
Xiaofeng Zhou, Ling Li, Scott P. Kelly, Heidi Leister-Tebbe, Steven G. Terra, Rongjun Shen, Mark Cullen,Michael Gaffney, Leo J. Russo
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 95-96
Cited0Views0Bibtex
0
0
Linear weighting to improve representativeness of patients with type 2 diabetes mellitus in US electronic health records
Stephen E. Schachterle, Ling Li, Thomas Edwards,Adina R. Lemeshow, Yaa Ababio, Kennedy P. Cook, Sandra Amaro, Leo J. Russo,Xiaofeng Zhou
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 399-400
Cited0Views0Bibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn